Novo Nordisk Foundation Excellence Grant for Young Researchers to Dr. Johannes Kettunen

Dr. Johannes Kettunen received funding for 5 years from the Novo Nordisk Foundation Excellence Grant for Young Researchers within Endocrinology and Metabolism. Novo Nordisk Foundation is funding Dr. Kettunen´s project, entitled HDL-mediated cholesterol efflux capacity - epidemiology, genetics and causality in cardiometabolic diseases, for 5 years (May 2017 – April 2022). The total sum of the grant is DKK 4,941,200 ie approximately 665,000 €. http://computationalmedicine.fi/bulletin#24.3.2017

Last updated: 28.3.2017